Search For "central drugs standard control organisation"
CDSCO requests WHO for report that establishes link of medical products by
Updated : 3 years, 8 months ago IST
New Delhi [India], October 6 (ANI): National Regulatory Authority, CDSCO has requested the World Health Organization (WHO) to share the report on the establishment of "causal relation to death" with the medical products manufactured by a Haryana-based company, Maiden Pharmaceutical Limite
Read More
CDSCO takes up urgent investigation on WHO's complaint for India-made coug
Updated : 3 years, 9 months ago IST
New Delhi [India], October 6 (ANI): After the World Health Organization (WHO) issued an alert on four India-made cough and cold syrups used for paediatric groups, the Central Drugs Standard Control Organisation (CDSCO) has taken up an urgent investigation in this regard.
Read More
Delhi HC grants bail to joint drug controller of CDSCO
Updated : 3 years, 9 months ago IST
Delhi [India], September 6 (ANI): The Delhi High Court on Tuesday granted bail to the Joint Drug Controller of the Central Drugs Standard Control Organisation (CDSCO) and a Biocon Biologics executive in a Rs 9 lakh bribery case.
Read More
Covaxin, Covishield given normal new drug permission in adult population w
Updated : 4 years, 5 months ago IST
New Delhi [India], January 27 (ANI): Union Health Minister Dr Mansukh Mandaviya on Thursday said that the Central Drugs Standard Control Organisation (CDSCO) has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permissio
Read More
Covaxin for 2-18 yrs: Centre examining Expert Committee recommendations, i
Updated : 4 years, 7 months ago IST
New Delhi [India], November 30 (ANI): The Central government is examining the recommendation of the Subject Expert Committee (SEC) regarding the grant of market authorization of Covaxin for the age group of 2 to 18 years for restricted use in an emergency situation subject to various cond
Read More
Central Drugs Standard Control Organisation extends Covaxin shelf life to
Updated : 4 years, 8 months ago IST
New Delhi [India], November 3 (ANI): Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin has received an extension of shelf life for up to 12 months from the date of manufacturing on Wednesday by India's pharmaceuticals and medical regulatory body.
Read More
LumiraDx receives approval for its COVID-19 Antigen test for use in India
Updated : 4 years, 8 months ago IST
London [UK], October 20 (ANI/NewsVoir): Today, LumiraDx, a next-generation point of care diagnostics testing company announced it has received emergency use approval by India's Central Drugs Standard Control Organisation for its SARS-CoV-2 Antigen test for use in India.
Read More
COVID-19: J&J applies for approval to conduct clinical trials on adole
Updated : 4 years, 10 months ago IST
New Delhi [India], August 20 (ANI): US pharma giant Johnson & Johnson has moved an application before the Central Drugs Standard Control Organisation (CDSCO) in India, seeking permission to conduct clinical trials of its single-dose Janssen vaccine against COVID-19 on adolescents (chi
Read More
Expert panel recommends trials on mixing Covaxin and Covishield
Updated : 4 years, 11 months ago IST
New Delhi [India], July 30 (ANI): The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Thursday recommended granting permission for trials of mixing COVID-19 vaccines--Covaxin and Covishield--said sources.
Read More
Zydus Cadila, first Indian Company gets recommendation for clinical trials
Updated : 5 years ago IST
New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been recommended to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drug
Read More
Lilly signs pact with Natco to accelerate availability of baricitinib for
Updated : 5 years, 1 month ago IST
New Delhi [India], May 17 (ANI): Eli Lilly and Company said on Monday it has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma, a local pharmaceutical manufacturer of generic medicines.
Read More
Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability
Updated : 5 years, 1 month ago IST
New Delhi [India], May 10 (ANI): US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharmaceutical to accelerate and expand the availability of baricitinib in India for Covid-19 patients.
Read More